Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-06-08T17:14:48.170Z Has data issue: false hasContentIssue false
  • English
  • Français

Paediatric heart failure trials…and tribulations

Published online by Cambridge University Press:  18 June 2007

Robert E. Shaddy
Robert E. Shaddy*
Affiliation:
Primary Children’s Medical Center, University of Utah School of Medicine, Salt Lake City, Utah, United States of America
*
Correspondence to: Robert E. Shaddy, MD, Cardiology, Primary Children’s Medical Center, University of Utah School of Medicine, 100 North Medical Drive, Salt Lake City, UT 84113. Tel: +801 662 5467; Fax: +801 662 5404; E-mail: robert.shaddy@intermountainmail.org
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Childrencardiac failureendpoints
Type
Editorial Comment
Information
Cardiology in the Young , Volume 17 , Issue 4 , August 2007 , pp. 354 - 355
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Norozi, K, Bahlmann, J, Raab, B, et al. . A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young 2007; 17: current issue….CrossRefGoogle ScholarPubMed
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9–13.CrossRefGoogle Scholar
3. Bristow, MR, Gilbert, EM, Abraham, WT, et al. . Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996; 94: 2807–2816.Google Scholar
4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001–2007.Google Scholar
5. Packer, M, Fowler, MB, Roecker, EB, et al. . Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194–2199.Google Scholar
6. Packer, M, Bristow, MR, Cohn, JN, et al. . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group [see comments]. N Engl J Med 1996; 334: 1349–1355.CrossRefGoogle ScholarPubMed
7. Kouatli, AA, Garcia, JA, Zellers, TM, Weinstein, EM, Mahony, L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 1997; 96: 1507–1512.CrossRefGoogle Scholar
8. Hechter, SJ, Fredriksen, PM, Liu, P, et al. . Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol 2001; 87: 660–663, A11.Google Scholar
9. Dore, A, Houde, C, Chan, KL, et al. . Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 2005; 112: 2411–2416.CrossRefGoogle ScholarPubMed
10. Small Clinical Trials: Issues and Challenges. Institute of Medicine, 2001. (Accessed at http://www.iom.edu/report.asp?id=5483).Google Scholar